Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8755062 | Auris Nasus Larynx | 2016 | 4 Pages |
Abstract
These results suggest that the increased expression of H1R mRNA due to treatment with OMZ or BKC might be one of the factors underlying the exacerbation of symptoms in patients with RM and those complicated with allergic rhinitis. The concomitant use of a nasal steroid might reduce the exacerbation of symptoms caused by BKC, although there remains a risk of developing histamine hypersensitivity from the long-term use of a topical steroid-containing BKC.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Masaki Kawabata, Junichiro Ohori, Yuichi Kurono,